MetaCap

CapsoVision (CV) vs Integer (ITGR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

CapsoVision (CV) has outperformed Integer (ITGR) over the past year, gaining 38.9% versus a gain of 22.0%. Integer is the larger company by market cap ($4.30 billion vs $348.0 million), about 12.4 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CV+38.85%ITGR+22.05%
+218%+84%-51%
Oct 7, 20251 yearOct 7, 2026
CV+48.64%ITGR+4.62%
+213%+77%-59%
Jun 30, 20255 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CV versus ITGR key metrics
MetricCVITGR
Share price$6.54$126.59
Market cap$348.00M$4.30B
1-day change+0.62%+0.09%
YTD return-38.82%+61.41%
1-year return+38.85%+22.05%
5-year return—+41.79%
P/E ratio (TTM)—34.59
Forward P/E—18.43
EPS (TTM)$-0.45$3.66
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$1.85B
Revenue growth (YoY)—+7.98%
Net income (latest FY)—$102.81M
Gross margin—26.99%
Operating margin—11.94%
Net margin—5.55%
52-week high$15.37$126.80
52-week low$4.38$62.00
Distance from 52-week high-57.45%-0.17%
Analyst consensusstrong_buynone
Avg. price target upside+45.26%-3.78%
Average volume158.95K986.14K
Shares outstanding53.21M34.00M
Employees9911,000
SectorHealthcareHealth Care
IndustryMedical DevicesBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Integer is about 12.4 times larger than CapsoVision by market value ($4.30B vs $348.00M).
  • CV has outperformed ITGR by 16.8 percentage points over the past year.
  • The two companies sit in different sectors: CapsoVision in Healthcare and Integer in Health Care.

About CapsoVision

CV stock →

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).

Healthcare · Medical Devices · 99 employees

About Integer

ITGR stock →

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 11,000 employees

CV vs ITGR FAQ

Which is bigger, CapsoVision or Integer?

Integer (ITGR) is larger, with a market capitalization of $4.30B compared with $348.00M for CapsoVision (CV).

Which stock has performed better over the past year, CV or ITGR?

CV returned +38.85% over the past 12 months, compared with +22.05% for ITGR (price return, excluding dividends). Past performance does not predict future results.

Are CapsoVision and Integer in the same industry?

No. CapsoVision is in the Healthcare sector, while Integer is in Health Care.

More comparisons